Interferon-γ and tumor necrosis factor-α induce synergistic cytolytic effects in ovarian cancer cell lines - Roles of the TR60 and TR80 tumor necrosis factor receptors

Gynecologic Oncology

Volumn 72, Issue 3, 1999, Pages 392-401

  Kost, Edward R ^a   Mutch, David G ^b   Herzog, Thomas J ^b  

^a BROOKE ARMY MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CYTOLYSIS; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; DRUG RECEPTOR BINDING; FEMALE; HUMAN; HUMAN CELL; LIGAND BINDING; MONOLAYER CULTURE; NORTHERN BLOTTING; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RECEPTOR DENSITY;

EID: 0032980768     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5257     Document Type: Article

References (25)

1. Demetri G D, Spriggs D R, Sherman M L, Arthur K A, Imamura K, Kufe D. A phase I trial of recombinant human tumor necrosis factor and interferon-gamma: Effects of combination cytokine administration in vivo. J Clin Oncol. 7:1989;1545-1549.
2. Kurzrock R, Feinberg B, Talpaz M, Saks S, Gutterman J U. Phase I study of a combination of recombinant tumor necrosis factor and recombinant interferon-γ in cancer patients. J Interferon Res. 9:1989;435-439.
3. Massad L S, Mutch D G, Kao M S, Powell C B, Collins J L. Inhibition of protein synthesis enhances the lytic effects of tumor necrosis factor alpha and interferon-gamma in cell lines derived from gynecologic malignancies. Cancer Immunol Immunother. 33:1991;183-188.
4. Adamson G M, Billings R E. Cytokine toxicity and induction of NO synthetase activity in cultured mouse hepatocytes. Toxicol Appl Pharmacol. 19:1993;100-107.
5. Scuderi P, Sterling K E, Raitano A B, Grogan T M, Rippe R A. Recombinant interferon-γ stimulates the production of human tumor necrosis factor in vitro. J Interferon Res. 7:1987;155-164.
6. Ruggiero V, Tavernier J, Fiers W, Baglioni C. Induction of the synthesis of tumor necrosis factor receptors by interferon-γ J Immunol. 136:1986;2445-2450.
7. Aggarwal B B, Eessalu T E. Induction of receptors for tumor necrosis factor-α by interferons is not a major mechanism for their synergistic cytotoxic response. J Biol Chem. 262:1987;10000-10007.
8. Kost E R, Herzog T J, Adler L M, Williams S, Mutch D G. The role of tumor necrosis factor-alpha-mediated cytolysis of ovarian cancer cell lines. Am J Obstet Gynecol. 174:1996;145-153.
9. Heller R A, Song K, Fan N, Chang D J. The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell. 70:1992;47-56.
10. Grell M, Scheurich P, Meager A, Pfizenmaier K. The TR60 and TR80 tumor necrosis factor (TNF-α)-receptors can independently mediate cytolysis. Lymph Cytol Res. 12:1993;143-148.
11. Medvedev A E, Sundan A, Espevik T. Involvement of the tumor necrosis factor receptor p75 in mediating cytotoxicity and gene regulating activities. Eur J Immunol. 24:1994;2842-2849.
12. Tartaglia L A, Goeddel D V, Reynolds C, Figari I S, Weber R F, Fendly B M, Palladino M A Jr. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J Immunol. 151:1993;4637-4641.
13. Abe Y, Yamauchi K, Kimura S. 75- but not 55-kDa tumor necrosis factor receptor is active in the homotypic aggregation and proliferation of human lymphokine-activated T killer (T-LAK) cell in vitro. J Leukocyte Biol. 57:1995;462-468.
14. Thoma B, Grell M, Pfizenmaier K, Scheurich P. Identification of a 60-Kd tumor necrosis factor (TNF-α) receptor as the major signaling transducing component in TNF-α responses. J Exp Med. 172:1990;1019-1024.
15. Ware C F, Crowe P D, Vanarsdale T L. Tumor necrosis factor (TNF-α) receptor expression in T lymphocytes. J Immunol. 147:1991;4229-4238.
16. Chirgwin J J, Przbyla A E, MacDonald R J, Rutter W J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
17. Hoof T, Riordan J R, Tummler B. Quantitation of mRNA by the kinetic polymerase chain reaction assay: A tool for monitoring p-glycoprotein gene expression. Anal Biochem. 196:1991;161-164.
18. Scatchard G. The attractions of proteins for small molecules and ions. Ann N Y Acad Sci. 51:1949;660-672.
19. Berenbaum M C. What is synergy. Pharm Rev. 41:1989;93-141.
20. Pandita R, Pocsik E, Aggarwal B B. Interferon-γ induces cell surface expression for both types of tumor necrosis factor receptor. FEBS. 312:1992;87-90.
21. Gatanaga M, Grosen E A, Burger R A, Granger G A, Gatanaga T. Release of soluble TNF/LT receptors from a human ovarian tumor cell line (PA-1) by stimulation with cytokines in vitro. Lymphokine Cytokine Res. 12:1993;249-253.
22. Lindvall L, Lantz M, Persson A M, Olsson I, Gullberg U. Independent transcriptional and posttranscriptional regulation of the two tumor necrosis factor receptors in promyelocytic HL-60 cells. Lymphokine Cytokine Res. 12:1993;205-212.
23. Aggarwal B B, Graft K, Samal B, Higuchi M, Liao W SL. Regulation of two forms of the TNF receptor by phorbol ester and dibutyryl cyclic adenosine 3′, 5′-monophosphate in human histiocytic lymphoma cell line U-937. Lymphokine Cytokine Res. 12:1993;149-158.
24. Powell C B, Mutch D G, Massad L S, Kao M S, Collins J L. Common expression of a tumor necrosis factor resistance mechanism among gynecologic malignancies. Cancer Immunol Immunother. 32:1990;131-136.
25. Massad L S, Mutch D G, Kao M S, Powell C B, Koa M S, Collins J L. Expression of a resistance mechanism in ovarian and cervical carcinoma cells prevents their lysis by γ-interferon. Cancer Res. 50:1990;4923-4928.